• 3493 Citations
  • 25 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yiyu Zou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Liposomes Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hepatic Artery Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2018

Azacitidine
Genetic Therapy
Lung Neoplasms
Lung
Epithelium
Small Cell Lung Carcinoma
Neoplasms
Genes
Therapeutics
Gene Expression

Publications 1989 2019

  • 3493 Citations
  • 25 h-Index
  • 63 Article
  • 1 Review article
1 Citation (Scopus)

Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma

Shenoy, N., Bhagat, T. D., Cheville, J., Lohse, C., Bhattacharyya, S., Tischer, A., Machha, V., Gordon-Mitchell, S., Choudhary, G., Wong, L. F., Gross, L. A., Ressigue, E., Leibovich, B., Boorjian, S. A., Steidl, U. G., Wu, X., Pradhan, K., Gartrell, B. A., Agarwal, B., Pagliaro, L. & 8 others, Suzuki, M., Greally, J. M., Rakheja, D., Houston Thompson, R., Susztak, K., Witzig, T., Zou, Y. & Verma, A. K., Apr 1 2019, In : Journal of Clinical Investigation. 129, 4, p. 1612-1625 14 p.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Ascorbic Acid
Methylation
Cytosine
Protein Transport
1 Citation (Scopus)

PAK kinase inhibition has therapeutic activity in novel preclinical models of adult T-Cell leukemia/lymphoma

Chung, E. Y. L., Mai, Y., Shah, U. A., Wei, Y., Ishida, E., Kataoka, K., Ren, X., Pradhan, K., Bartholdy, B. A., Wei, X., Zou, Y., Zhang, J., Ogawa, S., Steidl, U. G., Zang, X., Verma, A. K., Janakiram, M. & Ye, B. H., Jun 15 2019, In : Clinical Cancer Research. 25, 12, p. 3589-3601 13 p.

Research output: Contribution to journalArticle

p21-Activated Kinases
Adult T Cell Leukemia Lymphoma
Therapeutics
Cell Survival
Protein Isoforms
7 Citations (Scopus)

Notch pathway is activated via genetic and epigenetic alterations and is a therapeutic target in clear cell renal cancer

Bhagat, T. D., Zou, Y., Huang, S., Park, J., Palmer, M. B., Hu, C., Li, W., Shenoy, N., Giricz, O., Choudhary, G., Yu, Y., Ko, Y. A., Izquierdo, M. C., Park, A. S. D., Vallumsetla, N., Laurence, R., Lopez, R., Suzuki, M., Pullman, J. M., Kaner, J. & 8 others, Gartrell, B. A., Hakimi, A. A., Greally, J. M., Patel, B., Benhadji, K., Pradhan, K., Verma, A. K. & Susztak, K., Jan 20 2017, In : Journal of Biological Chemistry. 292, 3, p. 837-846 10 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Epigenomics
Chemical activation
Tumors
Cells
1 Citation (Scopus)

Pax5 Re-expression in H460 cells treated with the combination of demethylating agent and histone deacetylase inhibitor is associated with the enhancement of P53 binding to Pax5 promoter region

Liang, Y., Zeng, J., Jelicks, L., Ma, S., Liu, J., Mei, J., Perez-Soler, R. & Zou, Y., Feb 1 2017, In : Current Cancer Drug Targets. 17, 2, p. 169-176 8 p.

Research output: Contribution to journalReview article

Azacitidine
Histone Deacetylase Inhibitors
Genetic Promoter Regions
Non-Small Cell Lung Carcinoma
Transcription Factors

TRIB2 contributes to cisplatin resistance in small cell lung cancer

Liang, Y., Yu, D., Perez-Soler, R., Klostergaard, J. & Zou, Y., Jan 1 2017, In : Oncotarget. 8, 65, p. 109596-109608 13 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Cisplatin
CCAAT-Enhancer-Binding Protein-alpha
Neoplastic Stem Cells
Proteins